Brevinin-2R

General Information


DRACP ID  DRACP00196

Peptide Name   Brevinin-2R

Sequence  KLKNFAIGVAQSLLNKASCKLSGQC

Sequence Length  25

UniProt ID  P85095 

PubChem CID  Not available

Origin  Pelophylax ridibundus (Marsh frog) (Rana ridibunda)

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MCF-7 Invasive breast carcinoma of no special type Carcinoma LD50=10-15μg/ml MTT assay 4h 1
Jurkat Childhood T acute lymphoblastic leukemia; Precursor T-cell acute lymphoblastic leukemia Leukemia LD50=20-25μg/ml MTT assay 4h 1
BJAB Burkitt lymphoma Lymphoma LD50=30-40μg/ml MTT assay 4h 1

Hemolytic Activity  Sheep erythrocytes(2.5% hemolytic activity at 200 μg/ml)

Normal (non-cancerous) Cytotoxicity  L929: LD50=20-25μg/ml

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticance; Antimicrobial; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00196

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Not available

C-terminal Modification  Not available

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C114H197N33O33S2

Absent amino acids  DEHMPRTWY

Common amino acids  KL

Mass  305043

Pl  10.35

Basic residues  4

Acidic residues  0

Hydrophobic residues  10

Net charge  4

Boman Index  -1527

Hydrophobicity  17.2

Aliphatic Index  101.6

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  125

Absorbance 280nm  5.21

Polar residues  9

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 18494941

Title  Brevinin-2R(1) semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway

Doi 10.1111/j.1582-4934.2008.00129.x

Year  2008

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.